2nd Quarter - Report

HOOPER, LUNDY & BOOKMAN, P.C. for ROCHE DIAGNOSTICS CORPORATION

Period 2nd Quarter 2021 Filed Jul 20, 2021 Signed by Debra Jones

Official filing
Firm
HOOPER, LUNDY & BOOKMAN, P.C.
Client
ROCHE DIAGNOSTICS CORPORATION
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021" (H.R. 4128/S. 2209).

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2209 (117th), H.R. 4128 (117th)

Health Issues HCR

Issues related to diagnostic testing; "Access to TESTs Act" (H.R. 747/S. 1018); Issues related to inclusion of diagnostics in the Strategic National Stockpile; "United States Innovation and Competition Act of 2021" (S. 1260) relating to the Strategic National Stockpile; "Medical Supplies for Pandemics Act of 2021" (H.R. 3463/S. 1693).

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1693 (117th), S. 1018 (117th), S. 1260 (117th), H.R. 747 (117th), H.R. 3463 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.